Green and digital biomedical knowledge for interdisciplinary interfaculty further education of students and employees in biotechnological/biomedical companies or healthcare, with the aim of more effective integration into the labor market

EATRIS-TRI.SI

PERMEABLE

[Researcher on the beginning of their career 2.1]

ŠIPK - OptMutNGS [ŠIPK - Optimizing discovery of causal mutations for hereditary disease diagnosis with next generation sequencing.]

PKP - ModGenImuno [PKP - Advanced prediction models based on genomic and other molecular data to diagnose and monitor complex immune diseases.]

Current projects and collaborations: ARRS Slovenian Research and Innovation Agency

J3-4497  Non-invasive multi-omics biomarkers in immune cells subtypes for personalized medicine in childhood asthma and molecular mechanisms of non-response to inhaled corticosteroids. Duration: 2022 –2024.  Principal investigator: red. prof. dr. Uroš Potočnik (Medical Faculty, University of Maribor) (ARIS: J3-4497)

L4-1843  Innovative affinity-based system for blood cell separation. Duration: 1.7.2019 – 30.6.2022.  Principal investigator: dr. Boris Gole (Medical Faculty, University of Maribor)
J3-9258 Molecular genetic biomarkers and mechanisms of unresponsiveness to biological therapy anti-TNF in patients with chronic immune diseases Period: 1.7.2018―30.6.2021. Head: Potočnik Uroš
J3-9272 Identification of molecular biomarkers for prognosis of clinical outcome and metastasis in triple negative breast cancer patients. Period: 1.7.2018―30.6.2021. Head: Takač Iztok
J1-9169 Multifunctional bioactive coatings on different substrates for biomedical applications Period: 1.7.2018―30.6.2021. Head: Finšgar Matjaž
J3-9289 The role of cyclic adenosine monophosphate in normal beta cell physiology and during development of type 2 diabetes mellitus Period: 1.7.2018―30.6.2021. Head: Stožer Andraž

Current projects and collaborations

SFRH/BD/79804/2011: The endocannabinoid system in asthma patients and the effect of cannabinoids in the modulation of inflammatory response (Ministry of Science, Portugal), Principal Researcher: Uroš Potočnik
International Inflammatory bowel disease Genetics consortium (IIBDGC) (Slovene national consortium coordinator prof. Uroš Potočnik).

Completed projects and collaborations

SysPharmPedia

JTC1_99 SysPharmPedia, “Systems pharmacology approach to difficult-to-treat pediatric asthma” call ERA-Net ERACoSysMed "Collaboration on systems medicine funding to promote the implementation of systems biology approaches in clinical research and medical practice. Period: 1.5.2016―1.5.2019. U. Potočnik coordinator for Slovenia; collaborating with Neatherland, Spain, Germany.

J3-6785 Genetics and pharmacogenomics of inflammatory bowel diseases and genetically related chronic immune diseases Period: 1.7.2014―30.6.2017. Head: Potočnik Uroš
J3-6789 “Pathogenic mechanism of the C9orf72 expanded hexanucleotide repeat mutation in neurodegeneration; 2014-2017;
IRP-2013: Genetics of self-injury behavior; (Collaboration with University Clinical Center Maribor head UKC MB T. Bunderla; head of project at MF MB U. Potočnik); Period: 2013-2016;
IRP-2014/01-21: Nucleotide polymorphisms in genes SDF-1ɑ, MMP7, MMP9, TIMP2, RAD18 in MACC1 as prognostic factors for colorectal cancer (head of project at UKC MB M. Horvat; head of project at MF MB U. Potocnik); Period: 2013-2016
IRP-2014/01-30: Identificaition of monogenic mutations and DNA polymorphisms associated with risk for Parkinson disease in Slovenian patients (Collaboration with University Clinical Center Maribor head of project at UKC MB D. Flisar, head of project at MF MB U. Potocnik); Period: 2014-2017
IRP-2014/01-29: Identification of mutations and DNA polymorphisms in gene SCN9 in patients with complex regional pain syndrome (Collaboration with University Clinical Center Maribor head UKC MB D. Flisar; head of project at MF MB U. Potočnik); Period: 2014-2017
IRP-2015: Genetics of chronic kidney disease; (Collaboration with University Clinical Center Maribor head UKC MB S. Bevc; headof project at MF MB U. Potočnik); Period: 2015-2017
IRP-2015: Molecular genetic biomarkers for recurrence of Head and neck cancer; (Collaboration with University Clinical Center Maribor head UKC MB A. Čižmarević; head of project at MF MB U. Potočnik); Period: 2015-2018
P3-0067 “Pharmacology and pharmacogenomics” (head of project at MF UL Mojca Kržan; prof. U. Potočnik is authorized coordinator of Pharmacogenomics at MF MB, 2014-2017)
J3-2175 Gentski dejavniki tveganja in farmakogenomika kronično vnetne črevesne bolezni (Slovene) Period: 1.5.2009―30.4.2012. Head: Potočnik Uroš
J3-7141 Genetic susceptibility to gastrointestinal complex diseases and pharmacogenomics Period: 1.9.2005―31.8.2008. Head: Potočnik Uroš
V3-1505 Analysis and development of rare diseases field in Slovenia Period: 1.10.2015―30.9.2017. Head: Battelino Tadej
J3-6789 Pathogenic mechanism of the C9orf72 expanded hexanucleotide repeat mutation in neurodegeneration Period: 1.7.2014―30.6.2017. Head: Rogelj Boris
Z3-6028 Molekularno genetske raziskave kroničnih vnetij črevesa. Crohnova bolezen in ulcerativnikolitis (Slovene) Period: 1.2.2004―30.1.2006. Head: Ferluga Dušan
L3-5024 Incidence of erythropoietic protoporphyria and molecular mechanism in population of Slovenia Period: 1.1.2003―31.12.2005. Head: Krajnc Ivan
L3-5012 MOLEKULAR GENETIC PREDISPOSITION FOR DEVELOPMENT OF SOME CANCERS Period: 1.1.2003―31.12.2005. Head: Ravnik-Glavač Metka
L3-3435 Prion diseases and their diagnostics Period: 1.7.2001―30.6.2004. Head: Čurin Šerbec Vladka
BI-US/15-16-061 SLO-USA, (head dr. Uroš Potočnik) “Genetics and pharmacogenomics of chronic immune diseases”, collaboration with New York Genome Center, USA (Dr. Tuuli Lappalainen),. Period: 2015-2016
BI-US/06-07-050 SLO-USA, Molecular genetic and pharmacogenomic markers in complex gastrointestinal diseases (head dr. Uroš Potočnik), collaboration with NIH-National Cancer Institute, USA (Dr. Michael Dean). Period: 2006-2010